Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.

Hatime Arzu YasarHande TurnaEce EsinA Murat SedefAli AlkanBerna OksuzogluNuriye OzdemirMa Nahit SendurAhmet SezerSaadettin KılıckapGungor UtkanHakan AkbulutIsmail CelikHuseyin AbalıYuksel Urun

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

Ipilimumab therapy may be associated with increased survival, but this retrospective small N study makes that hard to definitely conclude.

Keyphrases

prognostic factors
free survival
palliative care
cross sectional
stem cells
mesenchymal stem cells
ulcerative colitis
skin cancer
smoking cessation